4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate has been researched along with beta-endorphin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ha, SS; Hiura, A; Nishiwaki, H; Satake, K; Umeyama, K | 1 |
| Ha, SS; Hiura, A; Nishiwaki, H; Satake, K | 1 |
2 other study(ies) available for 4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate and beta-endorphin
| Article | Year |
|---|---|
Effect of a new synthetic protease inhibitor on beta-endorphin release during acute pancreatitis in dogs.
Topics: Acute Disease; Animals; beta-Endorphin; Dogs; Female; Guanidines; Hemodynamics; Infusions, Intravenous; Lactates; Male; Pancreas; Pancreatitis; Serine Proteinase Inhibitors | 1991 |
The therapeutic effect of a new synthetic protease inhibitor (E-3123) on hemodynamic changes during experimental acute pancreatitis in dogs.
Topics: Acute Disease; Animals; beta-Endorphin; Blood Flow Velocity; Blood Pressure; Cardiac Output; Dogs; Female; Guanidines; Hemodynamics; Male; Pancreatitis; Renal Artery; Serine Proteinase Inhibitors | 1993 |